How wrong you are! Patrys had a solid R&D team who had developed their antibodies over years...they were "in house" personnel all now gone. They also had a dedicated lab in Germany plus personnel in the University dedicated to developing their pipeline...also all now gone.
Patents?? Yes, several of those but take a close look...................
Orphan drug status?? Yes, but only useful if the Abs ever get to market! If PAT-SM6 is not being developed, thenhow is it going to get to the market?
I have said all I am saying on this Company. Time to think about others who have something "real".
Funny trade???, page-18
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 5382389 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 2352699 | 1 |
View Market Depth
| Last trade - 16.12pm 02/08/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable